1996 - Fellow of John Simon Guggenheim Memorial Foundation
The scientist’s investigation covers issues in Chagas disease, Trypanosoma cruzi, Pharmacology, Immunology and Biochemistry. His Chagas disease research incorporates elements of Trypanosomiasis, Benznidazole, Chemotherapy and Nifurtimox. His research in Trypanosoma cruzi focuses on subjects like Biological activity, which are connected to Nuclear chemistry and Plasmodium falciparum.
His study connects In vivo and Pharmacology. The various areas that Julio A. Urbina examines in his Immunology study include Parasitic disease and Disease. He has included themes like Ultrastructure and Amastigote in his Biochemistry study.
His primary areas of study are Biochemistry, Trypanosoma cruzi, Chagas disease, Sterol and Amastigote. His work on Enzyme, Ergosterol and Squalene as part of general Biochemistry research is often related to Ketoconazole and Farnesyl-diphosphate farnesyltransferase, thus linking different fields of science. The study incorporates disciplines such as Biological activity, In vivo and Trypanosoma in addition to Trypanosoma cruzi.
His studies in Chagas disease integrate themes in fields like Trypanosomiasis, Benznidazole and Pharmacology. As a member of one scientific family, Julio A. Urbina mostly works in the field of Sterol, focusing on Phospholipid and, on occasion, Fatty acid. His Amastigote course of study focuses on Intracellular and Endoplasmic reticulum.
Julio A. Urbina mostly deals with Chagas disease, Pharmacology, Benznidazole, Posaconazole and Trypanosoma cruzi. Chagas disease is the subject of his research, which falls under Immunology. His research integrates issues of Parasitic disease and Disease in his study of Immunology.
His work carried out in the field of Pharmacology brings together such families of science as Amastigote, Biochemistry, Adult patients, Antifungal drug and Trypanocidal agent. His Benznidazole research includes themes of Pharmacokinetics, Clinical trial, Therapeutic index, Nifurtimox and Pharmacotherapy. His biological study spans a wide range of topics, including Cell culture, Genetically engineered, Fibrosis, Cardiac fibrosis and Western blot.
Julio A. Urbina mostly deals with Chagas disease, Posaconazole, Benznidazole, Pathology and Family medicine. Chagas disease is a subfield of Immunology that he explores. Other disciplines of study, such as Pentamidine, Leishmania, Ergosterol, Microbiology and Leishmaniasis, are mixed together with his Posaconazole studies.
His Benznidazole research integrates issues from Pharmacotherapy, Combination therapy, Drug, Pharmacology and Parasitemia. His work on Neglected tropical diseases as part of general Pathology study is frequently linked to Declaration, therefore connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Specific chemotherapy of Chagas disease: controversies and advances.
Julio A. Urbina;Roberto Docampo.
Trends in Parasitology (2003)
Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
Julio A. Urbina.
Acta Tropica (2010)
Chemotherapy of trypanosomiases and leishmaniasis
Simon L. Croft;Michael P. Barrett;Julio A. Urbina.
Trends in Parasitology (2005)
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Michael B. Martin;Joshua S. Grimley;Jared C. Lewis;Huel T. Heath.
Journal of Medicinal Chemistry (2001)
Molecular order and dynamics of phosphatidylcholine bilayer membranes in the presence of cholesterol, ergosterol and lanosterol: a comparative study using 2H-, 13C- and 31p-NMR spectroscopy
Julio A. Urbina;Sara Pekerar;Hong biao Le;Jessica Patterson.
Biochimica et Biophysica Acta (1995)
The challenges of Chagas Disease-- grim outlook or glimmer of hope.
Rick L Tarleton;Richard Reithinger;Julio A Urbina;Uriel Kitron.
PLOS Medicine (2007)
Chemotherapy of Chagas disease.
Julio A. Urbina.
Current Pharmaceutical Design (2002)
Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870
Julio A. Urbina;Gilberto Payares;Judith Molina;Cristina Sanoja.
Ergosterol biosynthesis and drug development for Chagas disease.
Julio A Urbina.
Memorias Do Instituto Oswaldo Cruz (2009)
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
Judith Molina;Olindo Martins-Filho;Zigman Brener;Alvaro J. Romanha.
Antimicrobial Agents and Chemotherapy (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: